Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

China · Delayed Price · Currency is CNY

17.41

+0.21 (1.22%)

Sep 30, 2026, 3:04 PM CST

Market Cap	20.41B -14.7%
Revenue (ttm)	2.24B -3.7%
Net Income	3.16B +37.8%
EPS	2.70 +39.2%
Shares Out	1.17B
PE Ratio	6.45
Forward PE	n/a
Dividend	0.50 (2.87%)
Ex-Dividend Date	Jul 8, 2026

Volume	6,066,142
Open	17.27
Previous Close	17.20
Day's Range	17.22 - 17.43
52-Week Range	16.36 - 22.08
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, re... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1957

Employees 5,050

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000623

Full Company Profile

Financial Performance

In 2025, SHE:000623's revenue was 2.34 billion, a decrease of -10.55% compared to the previous year's 2.61 billion. Earnings were 2.40 billion, an increase of 54.39%.

Financial Statements